3 studies found for: "methodist hospital" AND ebv-specific cytotoxic t-lymphocyte | Open Studies | United States, Texas | Houston
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
|3||Not yet recruiting||
Nivolumab With Epstein Barr Virus Specific T Cells (EB-VSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)
† Study has passed its completion date and status has not been verified in more than two years.